Company / Revenue per Share
Arcadia Biosciences, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$3.70
FY2025
5-year range
$0.60 / $12.22
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share returned to growth in FY2025 after 2 years of decline, reaching $3.70.
Based on SEC 10-K filings.
3.70 in FY2025 with a 5-year CAGR of +93.8%.
Declined from $12.04 to $3.70 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -32.9%
- 5-Year CAGR
- +93.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 6.7% year-over-year.
- Peak revenue per share was recorded in FY2022.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.70 | +6.7% |
| FY2024 | $3.47 | -71.2% |
| FY2023 | $12.04 | -1.5% |
| FY2022 | $12.22 | +1946.7% |
| FY2021 | $0.60 | +341.8% |
| FY2020 | $0.14 | -55.9% |
| FY2019 | $0.31 | -83.7% |
| FY2018 | $1.89 | +31.6% |
| FY2017 | $1.43 | +1069.7% |
| FY2016 | $0.12 | -96.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026